A comprehensive prognostic analysis of osimertinib treatment in advanced non-small cell lung cancer patients with acquired EGFR-T790M mutation: a real-world study

被引：0
|
作者：
Xin Tang
Yuan Li
Wen-lei Qian
Wei-feng Yan
Tong Pang
You-ling Gong
Zhi-gang Yang
机构：
[1] West China Hospital,Department of Radiology
[2] Sichuan University,Department of Thoracic Oncology and State Key Laboratory of Biotherapy, Cancer Center
[3] West China Hospital,undefined
[4] Sichuan University,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2022年 / 148卷
关键词：
Osimertinib; EGFR-T790M; Non-small cell lung cancer; Prognostic analysis; Real-world study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2475 / 2486
页数：11
相关论文
共 50 条
  • [1] A comprehensive prognostic analysis of osimertinib treatment in advanced non-small cell lung cancer patients with acquired EGFR-T790M mutation: a real-world study
    Tang, Xin
    Li, Yuan
    Qian, Wen-lei
    Yan, Wei-feng
    Pang, Tong
    Gong, You-ling
    Yang, Zhi-gang
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (09) : 2475 - 2486
  • [2] Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients with EGFR-T790M Mutation
    Yamada, T.
    Yoshimura, A.
    Takeda, T.
    Shiotsu, S.
    Hiranuma, O.
    Chihara, Y.
    Uchino, J.
    Takayama, K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1033 - S1033
  • [3] Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients with EGFR-T790M Mutation
    Yoshimura, Akihiro
    Yamada, Tadaaki
    Okura, Naoko
    Takeda, Takayuki
    Hirose, Kazuki
    Kubota, Yutaka
    Shiotsu, Shinsuke
    Hiranuma, Osamu
    Chihara, Yusuke
    Tamiya, Nobuyo
    Kaneko, Yoshiko
    Uchino, Junji
    Takayama, Koichi
    [J]. CANCERS, 2019, 11 (03)
  • [4] Real-world osimertinib for EGFR mutation-positive non-small-cell lung cancer with acquired T790M mutation
    Imamura, Fumio
    Kimura, Madoka
    Yano, Yukihiro
    Mori, Masahide
    Suzuki, Hidekazu
    Hirashima, Tomonori
    Ihara, Shouichi
    Komuta, Kiyoshi
    Shiroyama, Takayuki
    Nagatomo, Izumi
    Kumagai, Toru
    [J]. FUTURE ONCOLOGY, 2020, 16 (21) : 1537 - 1546
  • [5] Real-World Data on Osimertinib in Chinese Patients with Pretreated, EGFR T790M Mutation Positive, Advanced Non-Small Cell Lung Cancer: A Retrospective Study
    Peng, Da
    Shan, Dongfeng
    Dai, Chengcheng
    Li, Jie
    Wang, Zifan
    Huang, Ziyi
    Peng, Rui
    Zhao, Peng
    Ma, Xuezhen
    [J]. CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 2033 - 2039
  • [6] Cost-effectiveness of osimertinib in the UK for advanced EGFR-T790M non-small cell lung cancer
    Bertranou, Evelina
    Bodnar, Carolyn
    Dansk, Viktor
    Greystoke, Alastair
    Large, Samuel
    Dyer, Matthew
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (02) : 113 - 121
  • [7] Phase II trial of alternating osimertinib with gefitinib in patients with EGFR-T790M mutation positive advanced non-small cell lung cancer (Oscillate)
    Mersiades, Antony
    Pavlakis, Nick
    Kao, Steven
    John, Tom
    Lee, Chee Khoon
    Dawson, Sarah-Jane
    Wong, Stephen
    Tan, Lavinia
    Yip, Sonia
    Brown, Chris
    Livingstone, Ann
    Cheung, Yvonne
    Jurkovic, Hannora
    Stockler, Martin
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 199 - 200
  • [8] Real-world analysis of the EGFR T790M mutation in plasma and tissue biopsy from advanced non-small cell lung cancer
    Lee, Eun Hye
    Kwak, Se Hyun
    Kim, Chi Young
    Lee, Sang Hoon
    Kim, Eun Young
    Chang, Yoon Soo
    [J]. RESPIROLOGY, 2023, 28 : 99 - 100
  • [9] Real-World Study of Osimertinib in EGFR T790M-Mutated Non-Small Cell Lung Cancer (NSCLC): ASTRIS Canadian Cohort Analysis
    Cheema, P.
    Liu, G.
    Burkes, R.
    Owen, S.
    Yu, J.
    Hao, D.
    Rothenstein, J.
    Martel, S.
    Iqbal, M.
    Juergens, R.
    Lam, W.
    Laskin, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S803 - S803
  • [10] ASTRIS: A real world treatment study of osimertinib in patients (pts) with EGFR T790M positive non-small cell lung cancer (NSCLC).
    De Marinis, Filippo
    Cho, Byoung Chul
    Kim, Dong-Wan
    Kim, Sang-We
    Hochmair, Maximilian J.
    Metro, Giulio
    Vansteenkiste, Johan F.
    Vicente, David
    Solomon, Benjamin J.
    Cheema, Parneet K.
    Freitas, Helano C.
    Provencio, Mariano
    Chen, Yuh-Min
    Wu, Yi-Long
    Milner, Alvin
    Rigas, James R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345